| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8294640 | Biochemical and Biophysical Research Communications | 2018 | 22 Pages |
Abstract
GDNF administration may improve patient outcomes by reducing the demyelination of nerves and the expression of γ- and α7-nAChR.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Xin Wang, Su Min, Fei Xie, Jun Yang, Liang Li, Jingyuan Chen,